Dr. Veronica Brito, MD

Dr. Brito practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Brito's NPI, 1518232990, was assigned on March 19, 2012. Dr. Brito graduated from Fluminense Federal University Faculty of Medicine in 1999. Dr. Brito holds Texas license P2202.

Dr. Brito's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Brito's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Brito is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple. Dmand AI also links Dr. Brito to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brito practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Brito's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Brito is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Brito's licenses on file in 2 states: Texas and New York.

Dmand AI lists acute respiratory failure, asthma, bronchitis, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, sleep apnea and tobacco use among the conditions Dr. Brito treats.

CMS data shows 762 Medicare services from Dr. Brito across 10 procedure codes in 2024, for 513 Medicare patients. Medicare paid $44,363 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 513 Medicare patients who saw Dr. Brito in 2024. The largest group is 65 to 74, with 262 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brito's median patient age at 70, with 56% women.

In 2024, Dr. Brito wrote 719 Medicare Part D claims for 155 patients. 45% of them were for generic drugs. CMS names the drug for 566 of them, across 20 drugs with 11 or more claims each, at $1,100,291 in total drug cost. In 2023, CMS named 441 claims across 17 drugs.

Dr. Brito accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brito as offering telehealth.

Dmand AI links 19 papers to Dr. Brito, published from 2006 to 2020. 2010 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, Community-Acquired Infections and Cross Infection. Dr. Brito's most frequent co-authors are Michael Steven Niederman, MD, Shekhar A. Ghamande, MD and Shirley Fong Jones, MD.

Dmand AI links Dr. Brito to 1 clinical trial. Conditions studied include Pneumonia and Respiratory Tract Infections.

CMS Open Payments shows 5 general payments to Dr. Brito from 3 drug and device companies from 2017 to 2025. Education make up the largest share, 76% of the total. Vertex Pharmaceuticals Incorporated paid the most, $121.

Dr. Brito graduated from Fluminense Federal University Faculty of Medicine in 1999.

Dr. Brito is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.